These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 27180427)
21. Design of benzothiazole-1,3,4-thiadiazole conjugates: synthesis and anticonvulsant evaluation. Siddiqui N; Ahuja P; Malik S; Arya SK Arch Pharm (Weinheim); 2013 Nov; 346(11):819-31. PubMed ID: 24081512 [TBL] [Abstract][Full Text] [Related]
22. Anticonvulsant and Neurotoxicity of Some Novel 1-([1,3,4]thiadiazino[6,5- b]indol-3-yl Semicarbazides. Deshmukh R; Thakur AS; Jha AK; Kumar SP Cent Nerv Syst Agents Med Chem; 2015; 16(1):29-36. PubMed ID: 26100150 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and anticonvulsant activity of new n-mannich bases derived from 5-cyclopropyl-5-phenyl-hydantoins. Byrtus H; Obniska J; Czopek A; Kamiński K Arch Pharm (Weinheim); 2011 Apr; 344(4):231-41. PubMed ID: 21469172 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and anticonvulsant activity of novel purine derivatives. Wang SB; Jin P; Li FN; Quan ZS Eur J Med Chem; 2014 Sep; 84():574-83. PubMed ID: 25062008 [TBL] [Abstract][Full Text] [Related]
26. New benzo[d]thiazol-2-yl-aminoacetamides as potential anticonvulsants: synthesis, activity and prediction of molecular properties. Ali R; Siddiqui N Arch Pharm (Weinheim); 2015 Apr; 348(4):254-65. PubMed ID: 25782176 [TBL] [Abstract][Full Text] [Related]
27. Coumarin incorporated triazoles: a new class of anticonvulsants. Bhat MA; Al-Omar MA Acta Pol Pharm; 2011; 68(6):889-95. PubMed ID: 22125954 [TBL] [Abstract][Full Text] [Related]
28. Anticonvulsant activity of Schiff bases of isatin derivatives. Verma M; Pandeya SN; Singh KN; Stables JP Acta Pharm; 2004 Mar; 54(1):49-56. PubMed ID: 15050044 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and activity of di- or trisubstituted N-(phenoxyalkyl)- or N-{2-[2-(phenoxy)ethoxy]ethyl}piperazine derivatives on the central nervous system. Pańczyk K; Pytka K; Jakubczyk M; Rapacz A; Sałat K; Furgała A; Siwek A; Głuch-Lutwin M; Gryboś A; Słoczyńska K; Pękala E; Żmudzki P; Bucki A; Kołaczkowski M; Żelaszczyk D; Marona H; Waszkielewicz AM Bioorg Med Chem Lett; 2018 Jun; 28(11):2039-2049. PubMed ID: 29730027 [TBL] [Abstract][Full Text] [Related]
30. (Aryloxy)aryl semicarbazones and related compounds: a novel class of anticonvulsant agents possessing high activity in the maximal electroshock screen. Dimmock JR; Puthucode RN; Smith JM; Hetherington M; Quail JW; Pugazhenthi U; Lechler T; Stables JP J Med Chem; 1996 Sep; 39(20):3984-97. PubMed ID: 8831764 [TBL] [Abstract][Full Text] [Related]
31. Anticonvulsant activity of p-chlorophenyl substituted arylsemicarbazones--the role of primary terminal amino group. Pandeya SN; Mishra V; Ponnilavarasan I; Stables JP Pol J Pharmacol; 2000; 52(4):283-90. PubMed ID: 11345484 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and anticonvulsant activity of some novel 3-aryl amino/amino-4-aryl-5-imino-Delta2-1,2,4-thiadiazoline. Gupta A; Mishra P; Kashaw SK; Jatav V; Stables JP Eur J Med Chem; 2008 Apr; 43(4):749-54. PubMed ID: 17624632 [TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and anticonvulsant properties of new N-Mannich bases derived from 3-phenylpyrrolidine-2,5-diones. Kamiński K; Obniska J; Chlebek I; Wiklik B; Rzepka S Bioorg Med Chem; 2013 Nov; 21(21):6821-30. PubMed ID: 23993970 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of anticonvulsant and analgesic effects of benzyl- and benzhydryl ureides. Librowski T; Kubacka M; Meusel M; Scolari S; Müller CE; Gütschow M Eur J Pharmacol; 2007 Mar; 559(2-3):138-49. PubMed ID: 17250826 [TBL] [Abstract][Full Text] [Related]
36. Anticonvulsant activities of α-asaronol ((E)-3'-hydroxyasarone), an active constituent derived from α-asarone. He X; Bai Y; Zeng M; Zhao Z; Zhang Q; Xu N; Qin F; Wei X; Zhao M; Wu N; Li Z; Zhang Y; Fan TP; Zheng X Pharmacol Rep; 2018 Feb; 70(1):69-74. PubMed ID: 29331789 [TBL] [Abstract][Full Text] [Related]
37. Synthesis, anticonvulsant activity, and structure-activity relationships of sodium channel blocking 3-aminopyrroles. Unverferth K; Engel J; Höfgen N; Rostock A; Günther R; Lankau HJ; Menzer M; Rolfs A; Liebscher J; Müller B; Hofmann HJ J Med Chem; 1998 Jan; 41(1):63-73. PubMed ID: 9438023 [TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, anticonvulsant, and antiarrhythmic properties of novel N-Mannich base and amide derivatives of β-tetralinohydantoin. Czopek A; Byrtus H; Zagórska A; Siwek A; Kazek G; Bednarski M; Sapa J; Pawłowski M Pharmacol Rep; 2016 Oct; 68(5):886-93. PubMed ID: 27351944 [TBL] [Abstract][Full Text] [Related]
39. Design, anticonvulsive and neurotoxic properties of retrobenzamides. N-(Nitrophenyl)benzamides and N-(aminophenyl)benzamides. Bourhim M; Poupaert JH; Stables JP; Vallée L; Vamecq J Arzneimittelforschung; 1999 Feb; 49(2):81-7. PubMed ID: 10083974 [TBL] [Abstract][Full Text] [Related]
40. Synthesis of some novel 4-(4-chlorophenyl)-6-p-tolyl-(+)-pyrimidine derivatives and their anticonvulsant activity. Thakur DS; Rajak H; Kumar P; Vaishnav Y Acta Pol Pharm; 2011; 68(6):993-7. PubMed ID: 22125967 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]